Mavacamten for hypertrophic cardiomyopathy: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Detalles Bibliográficos
Autores principales: Beinfeld, Molly, Wasfy, Jason H, Walton, Surrey, Sarker, Jyotirmoy, Nhan, Emily, Rind, David M, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372974/
https://www.ncbi.nlm.nih.gov/pubmed/35199575
http://dx.doi.org/10.18553/jmcp.2022.28.3.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372974/
https://www.ncbi.nlm.nih.gov/pubmed/35199575
http://dx.doi.org/10.18553/jmcp.2022.28.3.369

Ejemplares similares